Scout | Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)

This opportunity is no longer accepting applications.

grant

Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)

This grant opportunity aims to advance the development of medications for treating Substance Use Disorders by funding impactful preclinical and clinical research projects. It supports large, short-term projects with up to $5 million per year for up to 3 years. These cooperative agreements involve close monitoring and significant scientific input from NIDA staff, and are designed to move medica…

Source

Agency: National Institutes of Health

Sub-agency: National Institute on Drug Abuse

Award

Award Ceiling: $5M

Funding Amount: $5M

Dates

Opportunity Released: January 3, 2025

Keywords

Substance Use Disorders

Medication Development

Preclinical Research

Clinical Research

FDA Approval

NIDA

Short-term Funding

Cooperative Agreements

High Impact Studies

Funding Opportunity

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers